189 related articles for article (PubMed ID: 35912465)
1. Salpingectomy, tubal ligation and hysteroscopic occlusion for sterilization.
Marchand GJ; Masoud AT; King AK; Brazil GM; Ulibarri HM; Parise JE; Arroyo AL; Coriell CL; Goetz SP; Moir CJ; Govindan ML
Minerva Obstet Gynecol; 2022 Oct; 74(5):452-461. PubMed ID: 35912465
[TBL] [Abstract][Full Text] [Related]
2. Hysteroscopic tubal sterilization: an evidence-based analysis.
McMartin K
Ont Health Technol Assess Ser; 2013; 13(21):1-35. PubMed ID: 24228084
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
Venkatesh KK; Clark LH; Stamilio DM
Am J Obstet Gynecol; 2019 Jan; 220(1):106.e1-106.e10. PubMed ID: 30170036
[TBL] [Abstract][Full Text] [Related]
4. Techniques for the interruption of tubal patency for female sterilisation.
Lawrie TA; Kulier R; Nardin JM
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD003034. PubMed ID: 27494193
[TBL] [Abstract][Full Text] [Related]
5. Postpartum Permanent Sterilization: Could Bilateral Salpingectomy Replace Bilateral Tubal Ligation?
Danis RB; Della Badia CR; Richard SD
J Minim Invasive Gynecol; 2016; 23(6):928-32. PubMed ID: 27234430
[TBL] [Abstract][Full Text] [Related]
6. The Role of Opportunistic Bilateral Salpingectomy vs Tubal Occlusion or Ligation for Ovarian Cancer Prophylaxis.
Ely LK; Truong M
J Minim Invasive Gynecol; 2017; 24(3):371-378. PubMed ID: 28087480
[TBL] [Abstract][Full Text] [Related]
7. Techniques for the interruption of tubal patency for female sterilisation.
Lawrie TA; Kulier R; Nardin JM
Cochrane Database Syst Rev; 2015 Sep; (9):CD003034. PubMed ID: 26343930
[TBL] [Abstract][Full Text] [Related]
8. Comparing options for females seeking permanent contraception in high resource countries: a systematic review.
Gormley R; Vickers B; Cheng B; Norman WV
Reprod Health; 2021 Jul; 18(1):154. PubMed ID: 34284794
[TBL] [Abstract][Full Text] [Related]
9. Hysteroscopic proximal tubal occlusion versus laparoscopic salpingectomy as a treatment for hydrosalpinges prior to IVF or ICSI: an RCT.
Dreyer K; Lier MC; Emanuel MH; Twisk JW; Mol BW; Schats R; Hompes PG; Mijatovic V
Hum Reprod; 2016 Sep; 31(9):2005-16. PubMed ID: 27209341
[TBL] [Abstract][Full Text] [Related]
10. Female tubal sterilization: the time has come to routinely consider removal.
Creinin MD; Zite N
Obstet Gynecol; 2014 Sep; 124(3):596-599. PubMed ID: 25162262
[TBL] [Abstract][Full Text] [Related]
11. Safety outcomes of female sterilization by salpingectomy and tubal occlusion.
Westberg J; Scott F; Creinin MD
Contraception; 2017 May; 95(5):505-508. PubMed ID: 28232128
[TBL] [Abstract][Full Text] [Related]
12. Review of Sterilization Techniques and Clinical Updates.
Clark NV; Endicott SP; Jorgensen EM; Hur HC; Lockrow EG; Kern ME; Jones-Cox CE; Dunlow SG; Einarsson JI; Cohen SL
J Minim Invasive Gynecol; 2018; 25(7):1157-1164. PubMed ID: 28939482
[TBL] [Abstract][Full Text] [Related]
13. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
Salvador S; Scott S; Francis JA; Agrawal A; Giede C
J Obstet Gynaecol Can; 2017 Jun; 39(6):480-493. PubMed ID: 28527613
[TBL] [Abstract][Full Text] [Related]
14. Hysteroscopic tubal sterilization: a health economic literature review.
Toronto Health Economic and Technology Assessment (THETA) Collaborative
Ont Health Technol Assess Ser; 2013; 13(22):1-25. PubMed ID: 24228085
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.
Melo P; Georgiou EX; Johnson N; van Voorst SF; Strandell A; Mol BWJ; Becker C; Granne IE
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD002125. PubMed ID: 33091963
[TBL] [Abstract][Full Text] [Related]
16. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; Finlayson SJ; Huntsman DG; Miller D; McAlpine JN
Am J Obstet Gynecol; 2018 Aug; 219(2):172.e1-172.e8. PubMed ID: 29852159
[TBL] [Abstract][Full Text] [Related]
17. Safety and Assisted Reproductive Technology Outcomes of Hysteroscopic Tubal Microinserts Versus Laparoscopic Proximal Tubal Occlusion or Salpingectomy for Hydrosalpinges Treatment.
Arora R; Shapiro H; Liu K; Arthur R; Cruickshank B; Sharma P; Glass K; Baratz A; Librach C; Greenblatt EM
J Obstet Gynaecol Can; 2020 Jun; 42(6):779-786. PubMed ID: 32224160
[TBL] [Abstract][Full Text] [Related]
18. Salpingectomy and Ovarian Cancer Prevention.
Harris AL
Nurs Womens Health; 2015 Dec-2016 Jan; 19(6):543-9. PubMed ID: 26682662
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of Complete Salpingectomy Compared With Standard Postpartum Tubal Ligation at Cesarean Delivery: A Randomized Controlled Trial.
Subramaniam A; Blanchard CT; Erickson BK; Szychowski J; Leath CA; Biggio JR; Huh WK
Obstet Gynecol; 2018 Jul; 132(1):20-27. PubMed ID: 29889762
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
